Role of CD133 in human embryonic stem cell proliferation and teratoma formation
Abstract Background Pluripotent stem cells (PSCs), including human embryonic stem cells (hESCs), hold great potential for regenerative medicine and cell therapy. One of the major hurdles hindering the clinical development of PSC-based therapy is the potential risk of tumorigenesis. CD133 (Prominin 1...
Main Authors: | Hua Wang, Peng Gong, Jie Li, Yudong Fu, Zhongcheng Zhou, Lin Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-05-01
|
Series: | Stem Cell Research & Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13287-020-01729-0 |
Similar Items
-
Prostate Cancer Stem Cells: The Role of CD133
by: Jianhui Yang, et al.
Published: (2022-11-01) -
The Utilization and Limitation of CD133 Epitopes in Lung Cancer Stem Cells Research
by: Yin CHEN, et al.
Published: (2011-10-01) -
The effect and molecular mechanism of hypoxia on proliferation and apoptosis of CD133+ renal stem cells
by: Hong Liu, et al.
Published: (2021-06-01) -
Similar Population of CD133+ and DDX4+ VSEL-Like Stem Cells Sorted from Human Embryonic Stem Cell, Ovarian, and Ovarian Cancer Ascites Cell Cultures: The Real Embryonic Stem Cells?
by: Irma Virant-Klun, et al.
Published: (2019-07-01) -
CD133 expression in patients with peripheral neuroblastic tumor: a systematic review
by: Hedieh Nazarzadeh, et al.
Published: (2015-10-01)